文献速递肿瘤 PET/CT甲状腺核医学

成人PSMA PET/CT甲状腺意外摄取回顾性分析:三级癌症转诊中心与大学医学中心的发病率、诊断及治疗/结局

Retrospective analysis of PSMA PET/CT thyroid incidental uptake in adults: incidence, diagnosis, and treatment/outcome in a tertiary cancer referral center and University Medical Center.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2022-01-15

该研究为回顾性队列研究,纳入2016年1月至2021年7月间PSMA PET/CT显示的61例甲状腺意外瘤(PTI)病例,几乎均为前列腺癌(再)分期。PTI报告率为1.1%,2例经组织学证实为甲状腺癌,未进一步检查者随访中位1.8年(1.1-3.3)内PTI均未具临床意义,6例(10%)死于原发癌。

要点

  • PSMA PET/CT甲状腺意外瘤报告率为1.1%。
  • 61例PTI中2例组织学证实为甲状腺癌。
  • 未行进一步甲状腺检查者随访中位1.8年PTI均无临床意义。

核心结论

  • 在这项大型双中心经验中,PSMA PET/CT甲状腺意外瘤的发病率低(1.1%)。
  • 不足一半的PTI病例接受了分析,恶性肿瘤风险虽低但不可忽视。
  • 采用标准诊断流程处理PTI时临床结局良好,而患者预后由原发恶性肿瘤决定。
  • 作者认为,是否分析和治疗PTI病例应作为癌症患者共享决策的一部分。

研究设计与样本

  • 回顾性队列研究,纳入2016年1月至2021年7月间PSMA PET/CT显示的61例PTI病例,几乎均用于前列腺癌(再)分期。
  • 回顾性审查纳入病例的医疗记录,收集PSMA PET/CT扫描、原发恶性肿瘤、甲状腺诊断、治疗及随访数据。

主要发现

  • 在本研究纳入的接受肿瘤PSMA PET/CT扫描的患者中,PTI报告率为1.1%。
  • 2例PTI经组织学证实为甲状腺癌:1例为良性甲状腺病变,1例为肾细胞癌转移。
  • 在任何形式进一步甲状腺检查被省略的病例中,随访期间(中位1.8年(1.1-3.3))PTI均未具临床意义。
  • 6例患者(10%)死于原发癌。

临床怎么用

  • 采用标准诊断流程处理PTI时临床结局良好。
  • 作者认为,是否分析和治疗PTI病例应作为癌症患者共享决策的一部分。

局限性

  • 不足一半的PTI病例接受了分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: A prostate-specific membrane antigen (PSMA) thyroid incidentaloma (PTI) is an unexpected, PSMA-avid thyroid lesion, newly detected during the investigation of an unrelated condition using PSMA PET/CT. The aim of this study is to examine the incidence and clinical significance of PTI and the associated management strategies since the implementation of the PSMA PET/CT scan. METHODS: This study involves a retrospective cohort study of 61 PTI cases depicted on PSMA PET/CT scans performed between January 2016 and July 2021, almost exclusively for (re)staging prostate cancer. The medical records of the included cases were retrospectively reviewed and data of the PSMA PET/CT scans, primary malignancy, thyroid diagnostics, treatment, and follow-up were collected. RESULTS: PTI was reported in 1.1% of the patients who underwent oncologic PSMA PET/CT scans included in this study. Two PTI cases had a histologically proven thyroid cancer: one a benign thyroid lesion and one a metastasis of a renal cell carcinoma. In none of the cases in whom any form of further thyroid workup was withheld, the PTI became clinically relevant during follow-up (median 1.8 years (1.1-3.3)). Six patients (10%) died due to their primary cancer. CONCLUSION: The incidence of thyroid incidentalomas on PSMA PET/CT was low (1.1%) in this large, two-center experience. Less than half of the PTI cases were analyzed and the risk of malignancy, despite being low, was not negligible. The clinical outcome was good using a standard diagnostic workup for PTI, while the prognosis of the patient was determined by the primary malignancy. The consideration to analyze and treat PTI cases should be part of the shared decision-making in cancer patients.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Piek MW, de Vries LH, Donswijk ML, et al. Retrospective analysis of PSMA PET/CT thyroid incidental uptake in adults: incidence, diagnosis, and treatment/outcome in a tertiary cancer referral center and University Medical Center. Eur J Nucl Med Mol Imaging. 2022. PMID: 35031811. doi:10.1007/s00259-022-05679-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。